|
|
|
|
|
|
|
|
|
06.05.26 - 14:03
|
Rhythm Pharmaceuticals Announces Participation in Upcoming Bank of America Global Healthcare Conference (GlobeNewswire EN)
|
|
|
BOSTON, May 06, 2026 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases, today announced that David Meeker, M.D., Chairman, President and Chief Executive Officer, will participate in a fireside chat at the upcoming Bank of America Global Healthcare Conference on Wednesday, May 13 at 3:00 p.m. PT in Las Vegas....
|
|
|
|
|
|
|
06.05.26 - 14:03
|
SPAR Group, Inc. Announces Timing of Fiscal 2026 First Quarter Results Conference Call (GlobeNewswire EN)
|
|
|
CHARLOTTE, N.C., May 06, 2026 (GLOBE NEWSWIRE) -- SPAR Group, Inc. (NASDAQ: SGRP) (“SPAR”, “SPAR Group” or the “Company”), an innovative services company offering comprehensive merchandising, marketing and distribution solutions to retailers and brands throughout the United States and Canada, today announces that it will release its 2026 first quarter results on Tuesday, May 12, 2026, before the market opens. In conjunction with the release, a conference call will be hosted by William Linnane, Chief Executive Officer, and Steve Hennen, Chief Financial Officer, at 9am ET on the same day. If you would like to submit questions for management to address during the hosted call, please email Sandy Martin (smartin@threepa.com) from Three Part Advisors....
|
|
|
|
|
|
|
06.05.26 - 14:03
|
Milestone Pharmaceuticals to Announce First Quarter 2026 Financial Results on May 13, 2026 (GlobeNewswire EN)
|
|
|
MONTREAL and CHARLOTTE, May 06, 2026 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced that it will report financial results for the first quarter ended March 31, 2026, and provide a business update before the market open. The announcement will be followed by a conference call and webcast for investors at 8:30am ET....
|
|
|
06.05.26 - 14:03
|
Apogee Minerals Closes Non-Brokered Private Placement Financing (GlobeNewswire EN)
|
|
|
Vancouver, BC, May 06, 2026 (GLOBE NEWSWIRE) -- Apogee Minerals Ltd. (“Apogee” or the “Company” or the “Optionee”) (TSXV: APMI) announces that, further to its news release dated April 27, 2026, it has closed a non-brokered private placement financing of 54,875,000 units at a price of $0.05 per unit (the “Units”) for gross proceeds of $2,743,750 (the “Offering”)....
|
|
|
|
|
|
|
|
|
06.05.26 - 14:03
|
Aktis Oncology to Present at the BofA Securities Health Care Conference (GlobeNewswire EN)
|
|
|
BOSTON, May 06, 2026 (GLOBE NEWSWIRE) -- Aktis Oncology, Inc. (NASDAQ:AKTS) (the “Company”), a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large populations, including those not addressed by existing platform technologies, today announced that Matthew Roden, Ph.D., President and Chief Executive Officer of Aktis Oncology, will present at the BofA Securities Health Care Conference in Las Vegas, Nevada. The presentation will take place on Wednesday, May 13, 2026, at 10:00 a.m. PT....
|
|
|
|
|
06.05.26 - 14:03
|
Annexon to Present at the Bank of America Securities Health Care Conference 2026 (GlobeNewswire EN)
|
|
|
BRISBANE, Calif., May 06, 2026 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at neuroinflammatory diseases that impact nearly 10 million people worldwide, today announced that Douglas Love, Esq., President and Chief Executive Officer, will present at the Bank of America Securities Health Care Conference 2026 on Wednesday, May 13, 2026 at 11:20 a.m. PT....
|
|
|
|
|
|
|
|